High-Flow Nasal Cannula Versus Nasal CPAP as Primary Support in Preterm Respiratory Distress Syndrome

This single-center randomized controlled trial compared heated humidified high-flow nasal cannula (HHHFNC) with nasal continuous positive airway pressure (nCPAP) as primary noninvasive respiratory support in preterm infants (gestational age 28-34 weeks; birth weight 1000-2000 g) with moderate respiratory distress syndrome. The primary outcome was treatment failure requiring invasive mechanical ventilation within the first 7 days.

NCT Number	NCT07693530
Lead Sponsor	Kayseri City Hospital
Conditions	Premature Birth, Respiratory Distress Syndrome, Newborn
Enrollment	86 participants
Start Date	2020-06-01
Primary Completion	2022-05-01 (estimated)
Study Completion	2022-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-09